WHO WE ARE
Minh Anh Medical is a trusted distributor of advanced medical devices and healthcare solutions in Vietnam. We are committed to delivering high-quality products that support healthcare professionals in improving patient outcomes and advancing clinical practice.
Our portfolio includes specialized solutions in wound care, surgical products, interventional therapies, and other medical technologies designed to meet the evolving needs of the healthcare industry.
Key Market
Ho Chi Minh City remains the company’s primary market, accounting for the majority of business activities and strategic hospital partnerships nationwide.
Central Region
Minh Anh Medical continues to strengthen its presence in Central Vietnam, including Da Nang and Binh Dinh, through collaborations with regional hospitals and healthcare providers.
Southern Region
The company has expanded its network throughout Southern Vietnam, including Can Tho, Dong Nai, and Kien Giang, supporting both public and private healthcare institutions.
HISTORY
2020
The company was officially established under the name PT Healthcare, with the mission of bringing advanced medical technologies and innovative healthcare solutions to the Vietnamese market.
Became the exclusive distributor of the TACE product line, marking the company’s first strategic partnership in the interventional healthcare field.
2021
Expanded into the neurovascular intervention field through the distribution of stroke intervention devices.
2022
Expanded the interventional portfolio with advanced embolization materials.
2023
Strengthened the product portfolio with peripheral, biopsy, and accessory solutions for interventional procedures.
2024
Expanded capabilities in advanced intervention through the distribution of neurovascular and peripheral thrombectomy product lines.
2025
Expanded into the cardiovascular field with comprehensive interventional and cardiovascular support systems.
2026
Officially changed the company name from PT Healthcare to Minh Anh Medical, marking a new stage of growth and long-term commitment to healthcare development in Vietnam.
Expanded the interventional cardiology portfolio through a new strategic collaboration partnership.
Entered the advanced wound care sector through a new distribution agreement for wound care solutions.
Strengthened the hepatic and portal intervention portfolio through the distribution of TIPS stent.
Expanded into the heart valve field through a strategic partnership for cardiovascular products.